Skip to main content
. Author manuscript; available in PMC: 2021 Mar 30.
Published in final edited form as: Int J Pharm. 2020 Jan 29;578:119090. doi: 10.1016/j.ijpharm.2020.119090

Figure 6:

Figure 6:

Mechanism of rhodamine nanoparticle uptake in bEnd.3 cells. Flow cytometry histograms (left) are representatives of cell blank, rhodamine nanoparticles alone and with uptake inhibitor treatments. The plot (right) indicates the quantification of fluorescence intensity with respective uptake inhibitors, with genistein treatment showing significant reduction in uptake (**p<0.01).